Apoptosis and autophagy in breast cancer cells following exemestane treatment

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Amaral, Cristina ^a,b   Borges, Margarida ^a,b   Melo, Soraia ^a,c   da Silva, Elisiário Tavares ^d   Correia da Silva, Georgina ^a,b   Teixeira, Natércia ^a,b  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c UNIVERSITY OF COIMBRA   (Portugal)

^d UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYLADENINE; CASPASE; EXEMESTANE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; AUTOPHAGY; BREAST CANCER; CANCER SURVIVAL; CELL CYCLE G0 PHASE; CELL STRAIN MCF 7; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; ENZYME ACTIVATION; G1 PHASE CELL CYCLE CHECKPOINT; G2 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; M PHASE CELL CYCLE CHECKPOINT; MITOCHONDRION; MITOSIS INHIBITION; SIGNAL TRANSDUCTION;

ANDROSTADIENES; ANTINEOPLASTIC AGENTS; APOPTOSIS; AROMATASE; AUTOPHAGY; BREAST NEOPLASMS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; RECEPTORS, ESTROGEN;

EID: 84865060393     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0042398     Document Type: Article

References (53)

1. Macedo LF, Sabnis G, Brodie A, (2009) Aromatase inhibitors and breast cancer. Ann N Y Acad Sci 1155: 162-173.
2. Gluck S, (2010) Exemestane as first-line therapy in postmenopausal women with recurrent or metastatic breast cancer. Am J Clin Oncol 33: 314-319.
3. Fabian CJ, (2007) The what, why and how of aromatase inhibitors: hormonal agents for treatment and prevention of breast cancer. Int J Clin Pract 61: 2051-2063.
4. Lonning PE, (2009) Lack of complete cross-resistance between different aromatase inhibitors; a real finding in search for an explanation? Eur J Cancer 45: 527-535.
5. Dutta U, Pant K, (2008) Aromatase inhibitors: past, present and future in breast cancer therapy. Med Oncol 25: 113-124.
6. Miller WR, Bartlett J, Brodie AM, Brueggemeier RW, di Salle E, et al. (2008) Aromatase inhibitors: are there differences between steroidal and nonsteroidal aromatase inhibitors and do they matter? Oncologist 13: 829-837.
7. Deeks ED, Scott LJ, (2009) Exemestane: a review of its use in postmenopausal women with breast cancer. Drugs 69: 889-918.
8. Wang X, Chen S, (2006) Aromatase destabilizer: novel action of exemestane, a food and drug administration-approved aromatase inhibitor. Cancer Res 66: 10281-10286.
9. Doisneau-Sixou SF, Sergio CM, Carroll JS, Hui R, Musgrove EA, et al. (2003) Estrogen and antiestrogen regulation of cell cycle progression in breast cancer cells. Endocr Relat Cancer 10: 179-186.
10. Gross JM, Yee D, (2003) The type-1 insulin-like growth factor receptor tyrosine kinase and breast cancer: biology and therapeutic relevance. Cancer Metastasis Rev 22: 327-336.
11. Nicholson RI, McClelland RA, Gee JM, Manning DL, Cannon P, et al. (1994) Epidermal growth factor receptor expression in breast cancer: association with response to endocrine therapy. Breast Cancer Res Treat 29: 117-125.
12. Kyprianou N, English HF, Davidson NE, Isaacs JT, (1991) Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation. Cancer Res 51: 162-166.
13. Thiantanawat A, Long BJ, Brodie AM, (2003) Signaling pathways of apoptosis activated by aromatase inhibitors and antiestrogens. Cancer Res 63: 8037-8050.
14. Detre S, Salter J, Barnes DM, Riddler S, Hills M, et al. (1999) Time-related effects of estrogen withdrawal on proliferation- and cell death-related events in MCF-7 xenografts. Int J Cancer 81: 309-313.
15. Truchet I, Jozan S, Guerrin M, Mazzolini L, Vidal S, et al. (2000) Interconnections between E2-dependent regulation of cell cycle progression and apoptosis in MCF-7 tumors growing on nude mice. Exp Cell Res 254: 241-248.
16. Kallio A, Zheng A, Dahllund J, Heiskanen KM, Harkonen P, (2005) Role of mitochondria in tamoxifen-induced rapid death of MCF-7 breast cancer cells. Apoptosis 10: 1395-1410.
17. Nazarewicz RR, Zenebe WJ, Parihar A, Larson SK, Alidema E, et al. (2007) Tamoxifen induces oxidative stress and mitochondrial apoptosis via stimulating mitochondrial nitric oxide synthase. Cancer Res 67: 1282-1290.
18. Lim KB, Ng CY, Ong CK, Ong CS, Tran E, et al. (2001) Induction of apoptosis in mammary gland by a pure anti-estrogen ICI 182780. Breast Cancer Res Treat 68: 127-138.
19. Samaddar JS, Gaddy VT, Duplantier J, Thandavan SP, Shah M, et al. (2008) A role for macroautophagy in protection against 4-hydroxytamoxifen-induced cell death and the development of antiestrogen resistance. Mol Cancer Ther 7: 2977-2987.
20. Qadir MA, Kwok B, Dragowska WH, To KH, Le D, et al. (2008) Macroautophagy inhibition sensitizes tamoxifen-resistant breast cancer cells and enhances mitochondrial depolarization. Breast Cancer Res Treat 112: 389-403.
21. de Medina P, Payre B, Boubekeur N, Bertrand-Michel J, Terce F, et al. (2009) Ligands of the antiestrogen-binding site induce active cell death and autophagy in human breast cancer cells through the modulation of cholesterol metabolism. Cell Death Differ 16: 1372-1384.
22. de Medina P, Silvente-Poirot S, Poirot M, (2009) Tamoxifen and AEBS ligands induced apoptosis and autophagy in breast cancer cells through the stimulation of sterol accumulation. Autophagy 5: 1066-1067.
23. Itoh T, Karlsberg K, Kijima I, Yuan YC, Smith D, et al. (2005) Letrozole-, anastrozole-, and tamoxifen-responsive genes in MCF-7aro cells: a microarray approach. Mol Cancer Res 3: 203-218.
24. Cepa MM, Tavares da Silva EJ, Correia-da-Silva G, Roleira FM, Teixeira NA, (2005) Structure-activity relationships of new A,D-ring modified steroids as aromatase inhibitors: design, synthesis, and biological activity evaluation. J Med Chem 48: 6379-6385.
25. Cepa M, Correia-da-Silva G, Tavares da Silva EJ, Roleira FM, Hong Y, et al. (2008) Molecular mechanisms of aromatase inhibition by new A, D-ring modified steroids. Biol Chem 389: 1183-1191.
26. Cepa M, Correia-da-Silva G, da Silva EJ, Roleira FM, Borges M, et al. (2008) New steroidal aromatase inhibitors: suppression of estrogen-dependent breast cancer cell proliferation and induction of cell death. BMC Cell Biol 9: 41.
27. Chen Y, Azad MB, Gibson SB, (2010) Methods for detecting autophagy and determining autophagy-induced cell death. Can J Physiol Pharmacol 88: 285-295.
28. Paglin S, Hollister T, Delohery T, Hackett N, McMahill M, et al. (2001) A novel response of cancer cells to radiation involves autophagy and formation of acidic vesicles. Cancer Res 61: 439-444.
29. DiPaola RS, (2002) To arrest or not to G(2)-M Cell-cycle arrest: commentary re: A. K. Tyagi et al., Silibinin strongly synergizes human prostate carcinoma DU145 cells to doxorubicin-induced growth inhibition, G(2)-M arrest, and apoptosis. Clin. cancer res., 8: 3512-3519, 2002. Clin Cancer Res 8: 3311-3314.
30. Kroemer G, Galluzzi L, Brenner C, (2007) Mitochondrial membrane permeabilization in cell death. Physiol Rev 87: 99-163.
31. Klionsky DJ, Abeliovich H, Agostinis P, Agrawal DK, Aliev G, et al. (2008) Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy 4: 151-175.
32. Madden DT, Egger L, Bredesen DE, (2007) A calpain-like protease inhibits autophagic cell death. Autophagy 3: 519-522.
33. Lemasters JJ, Qian T, He L, Kim JS, Elmore SP, et al. (2002) Role of mitochondrial inner membrane permeabilization in necrotic cell death, apoptosis, and autophagy. Antioxid Redox Signal 4: 769-781.
34. Dewaele M, Maes H, Agostinis P, (2010) ROS-mediated mechanisms of autophagy stimulation and their relevance in cancer therapy. Autophagy 6: 838-854.
35. Hou W, Han J, Lu C, Goldstein LA, Rabinowich H, (2010) Autophagic degradation of active caspase-8: a crosstalk mechanism between autophagy and apoptosis. Autophagy 6: 891-900.
36. Ferreira CG, Span SW, Peters GJ, Kruyt FA, Giaccone G, (2000) Chemotherapy triggers apoptosis in a caspase-8-dependent and mitochondria-controlled manner in the non-small cell lung cancer cell line NCI-H460. Cancer Res 60: 7133-7141.
37. de Vries JF, Wammes LJ, Jedema I, van Dreunen L, Nijmeijer BA, et al. (2007) Involvement of caspase-8 in chemotherapy-induced apoptosis of patient derived leukemia cell lines independent of the death receptor pathway and downstream from mitochondria. Apoptosis 12: 181-193.
38. Boya P, Gonzalez-Polo RA, Casares N, Perfettini JL, Dessen P, et al. (2005) Inhibition of macroautophagy triggers apoptosis. Mol Cell Biol 25: 1025-1040.
39. Eisenberg-Lerner A, Bialik S, Simon HU, Kimchi A, (2009) Life and death partners: apoptosis, autophagy and the cross-talk between them. Cell Death Differ 16: 966-975.
40. Eisenberg-Lerner A, Kimchi A, (2009) The paradox of autophagy and its implication in cancer etiology and therapy. Apoptosis 14: 376-391.
41. Sun WL, Chen J, Wang YP, Zheng H, (2011) Autophagy protects breast cancer cells from epirubicin-induced apoptosis and facilitates epirubicin-resistance development. Autophagy 7: 1035-1044.
42. Kanematsu S, Uehara N, Miki H, Yoshizawa K, Kawanaka A, et al. (2010) Autophagy inhibition enhances sulforaphane-induced apoptosis in human breast cancer cells. Anticancer Res 30: 3381-3390.
43. Abedin MJ, Wang D, McDonnell MA, Lehmann U, Kelekar A, (2007) Autophagy delays apoptotic death in breast cancer cells following DNA damage. Cell Death Differ 14: 500-510.
44. Yan CH, Yang YP, Qin ZH, Gu ZL, Reid P, et al. (2007) Autophagy is involved in cytotoxic effects of crotoxin in human breast cancer cell line MCF-7 cells. Acta Pharmacol Sin 28: 540-548.
45. Lemasters JJ, (1998) The mitochondrial permeability transition: from biochemical curiosity to pathophysiological mechanism. Gastroenterology 115: 783-786.
46. Zhivotovsky B, Orrenius S, (2010) Cell death mechanisms: cross-talk and role in disease. Exp Cell Res 316: 1374-1383.
47. Gozuacik D, Kimchi A, (2004) Autophagy as a cell death and tumor suppressor mechanism. Oncogene 23: 2891-2906.
48. Zhou DJ, Pompon D, Chen SA, (1990) Stable expression of human aromatase complementary DNA in mammalian cells: a useful system for aromatase inhibitor screening. Cancer Res 50: 6949-6954.
49. Sun XZ, Zhou D, Chen S, (1997) Autocrine and paracrine actions of breast tumor aromatase. A three-dimensional cell culture study involving aromatase transfected MCF-7 and T-47D cells. J Steroid Biochem Mol Biol 63: 29-36.
50. Masri S, Phung S, Wang X, Wu X, Yuan YC, et al. (2008) Genome-wide analysis of aromatase inhibitor-resistant, tamoxifen-resistant, and long-term estrogen-deprived cells reveals a role for estrogen receptor. Cancer Res 68: 4910-4918.
51. Berthois Y, Katzenellenbogen JA, Katzenellenbogen BS, (1986) Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture. Proc Natl Acad Sci U S A 83: 2496-2500.
52. Kurokawa H, Nishio K, Fukumoto H, Tomonari A, Suzuki T, et al. (1999) Alteration of caspase-3 (CPP32/Yama/apopain) in wild-type MCF-7, breast cancer cells. Oncol Rep 6: 33-37.
53. Chen X, Zhong Z, Xu Z, Chen L, Wang Y, (2010) 2′,7′-Dichlorodihydrofluorescein as a fluorescent probe for reactive oxygen species measurement: Forty years of application and controversy. Free Radic Res 44: 587-604.